These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. Abumayyaleh M; El-Battrawy I; Behnes M; Borggrefe M; Akin I Future Cardiol; 2020 Jul; 16(4):227-236. PubMed ID: 32186406 [TBL] [Abstract][Full Text] [Related]
43. Pharmacology of heart failure: From basic science to novel therapies. Lother A; Hein L Pharmacol Ther; 2016 Oct; 166():136-49. PubMed ID: 27456554 [TBL] [Abstract][Full Text] [Related]
44. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. Desai AS; Vaduganathan M; Cleland JG; Claggett BL; Barkoudah E; Finn P; McCausland FR; Yilmaz MB; Lefkowitz M; Shi V; Pfeffer MA; McMurray JJV; Solomon SD Circ Heart Fail; 2021 Dec; 14(12):e008597. PubMed ID: 34807713 [TBL] [Abstract][Full Text] [Related]
45. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. Solomon SD; Rizkala AR; Gong J; Wang W; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; Desai AS; Shi VC; Lefkowitz MP; McMurray JJV JACC Heart Fail; 2017 Jul; 5(7):471-482. PubMed ID: 28662936 [TBL] [Abstract][Full Text] [Related]
46. Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction. Mohanty AF; Levitan EB; King JB; Dodson JA; Vardeny O; Cook J; Herrick JS; He T; Patterson OV; Alba PR; Russo PA; Obi EN; Choi ME; Fang JC; Bress AP J Am Heart Assoc; 2021 Oct; 10(20):e020474. PubMed ID: 34612065 [TBL] [Abstract][Full Text] [Related]
47. Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF. Docherty KF; Vaduganathan M; Solomon SD; McMurray JJV JACC Heart Fail; 2020 Oct; 8(10):800-810. PubMed ID: 33004114 [TBL] [Abstract][Full Text] [Related]
49. Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives. Yandrapalli S; Andries G; Biswas M; Khera S Vasc Health Risk Manag; 2017; 13():369-382. PubMed ID: 29042791 [TBL] [Abstract][Full Text] [Related]
50. Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. Selvaraj S; Claggett BL; Pfeffer MA; Desai AS; Mc Causland FR; McGrath MM; Anand IS; van Veldhuisen DJ; Kober L; Janssens S; Cleland JGF; Pieske B; Rouleau JL; Zile MR; Shi VC; Lefkowitz MP; McMurray JJV; Solomon SD Eur J Heart Fail; 2020 Nov; 22(11):2093-2101. PubMed ID: 32840930 [TBL] [Abstract][Full Text] [Related]
51. Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction : A retrospective cohort study. De Vecchis R; Ariano C; Di Biase G; Noutsias M Herz; 2019 Aug; 44(5):425-432. PubMed ID: 29350254 [TBL] [Abstract][Full Text] [Related]
53. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings. Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170 [TBL] [Abstract][Full Text] [Related]
54. Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage. Upadhya B; Kozak PM; Stacey RB; Vasan RS Curr Hypertens Rep; 2022 Jan; 24(1):1-20. PubMed ID: 35165832 [TBL] [Abstract][Full Text] [Related]
55. Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction. Dereli S; Kılınçel O; Çerik İB; Kaya A Acta Cardiol; 2020 Dec; 75(8):774-782. PubMed ID: 32186467 [No Abstract] [Full Text] [Related]
56. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction. Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Pfeffer MA; Claggett B; Lewis EF; Granger CB; Køber L; Maggioni AP; Mann DL; McMurray JJV; Rouleau JL; Solomon SD; Steg PG; Berwanger O; Cikes M; De Pasquale CG; East C; Fernandez A; Jering K; Landmesser U; Mehran R; Merkely B; Vaghaiwalla Mody F; Petrie MC; Petrov I; Schou M; Senni M; Sim D; van der Meer P; Lefkowitz M; Zhou Y; Gong J; Braunwald E; N Engl J Med; 2021 Nov; 385(20):1845-1855. PubMed ID: 34758252 [TBL] [Abstract][Full Text] [Related]